About AQEMIA

AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.

Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.

We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization.

About the team you’ll join

As a Staff AI Research Scientist, you will join Aqemia’s Drug Discovery Platform Teams and lead efforts to develop cutting-edge AI algorithms to model protein-ligand systems. 

You will collaborate closely with AI researchers, computational chemists, and drug discovery experts to integrate your innovations into Aqemia’s platform, ensuring direct impact on the discovery of novel therapeutics.

What Does “Staff” Mean at Aqemia?

A Staff AI Research Scientist at Aqemia is both a hands-on technical expert and a leader, ensuring that AI innovation is effectively integrated into our Drug Discovery Platform.

This means you will be

Key Responsibilities

Qualifications

Preferred Mindset

Aqemia’s Recruitment team leads all recruitment activities for the company. We will not recognise any notional ownership recruitment companies claim over candidates presented directly to hiring managers without our Recruitment team's consent. Unsolicited resumes sent to us from recruiters do not constitute any type of relationship between the recruiter and Aqemia, and we will not be obligated to pay fees should we hire from those resumes.

Why Join Us ?

At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.

Expanding Drug Discovery Pipeline : Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.

Interdisciplinary Team : brilliant talent from tech and life sciences.

DeepTech Recognition: Part of French Tech 120 and France 2030.

Prime Location : Based in central Paris and London (King's Cross) with the possibility of 2 remote days per week.

International Environment : The work language is English - relocation support and French lessons granted if needed.

Strong Financial Backing : $100M raised from leading European and International investors